# Management Concepts of Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) Among Chinese Physicians

> **NCT07682363** · — · RECRUITING · sponsor: **Novo Nordisk A/S** · enrollment: 470 (estimated)

## Conditions studied

- Liver Disease

## Interventions

- **OTHER:** No treatment is given

## Key facts

- **NCT ID:** NCT07682363
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-03
- **Primary completion:** 2027-02-23
- **Final completion:** 2027-02-23
- **Target enrollment:** 470 (ESTIMATED)
- **Last updated:** 2026-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07682363

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07682363, "Management Concepts of Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) Among Chinese Physicians". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07682363. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*